A new type of treatment for osteoarthritis, currently in canine clinical trials, shows promise for eventual use in humans.
The treatment, developed by Cornell biomedical engineers, is a synthetic version of a naturally occurring joint lubricant that binds to the surface of cartilage in joints and acts as a cushion during high-impact activities, such as running.
“When the production of that specific lubricant goes down, it creates higher contact between the surfaces of the joint and, over time, it leads to osteoarthritis,” said David Putnam, a professor in the College of Engineering with appointments in the Meinig School of Biomedical Engineering and the Smith School of Chemical and Biomolecular Engineering.
Putnam is senior author of “Boundary Mode Lubrication of Articular Cartilage With a Biomimetic Diblock Copolymer,” published June 4 in Proceedings of the National Academy of Sciences, USA. Zhexun Sun, a postdoctoral researcher in Putnam’s lab, is the paper’s first author.
The study focuses on a naturally occurring joint lubricant called lubricin, the production of which declines following traumatic injuries to a joint, such as a ligament tear in a knee.
The knee is lubricated in two ways – hydrodynamic mode and boundary mode.
Hydrodynamic mode lubrication occurs when the joint is moving fast and there isn’t a strong force pushing down on it. In this mode, joints are lubricated by compounds like hyaluronic acid (HA) that are thick and gooey, like car oil. There are numerous HA products on the market, approved by the Food and Drug Administration, for treating hydrodynamic mode lubrication disorders.
But HA is ineffective when strong forces are pushing down on the joint, such as those that occur during running or jumping. In these instances, thick gooey HA squirts out from between the cartilage surfaces, and boundary mode lubrication is necessary. Under these forces, lubricin binds to the surface of the cartilage. It contains sugars that hold on to water, to cushion hard forces on the knee.
In the paper, the researchers describe a synthetic polymer they developed that mimics the function of lubricin and is much easier to produce. “We are in clinical trials, with dogs that have osteoarthritis, with our collaborators at Cornell’s College of Veterinary Medicine,” Putnam said.
Those collaborators – Ursula Krotscheck and Kei Hayashi, both associate professors in the Section of Small Animal Surgery in the Department of Clinical Sciences – use a force plate to measure the efficacy of the treatments. The force plate quantifies the amount of force that a dog exerts with each paw, to measure whether they are favoring one paw over another.
“Once we finalize the efficacy study in dogs, we will be in a very good position to market the material for veterinary osteoarthritis treatment,” Putnam said. From there, the human market for a lubricin substitute should follow, just as HA has been made available for human use, mainly in knees.
The Latest on: Osteoarthritis
via Google News
The Latest on: Osteoarthritis
- Manufacturers claim CBD pet products can ease anxiety, osteoarthritis and pain in four-legged friendson September 6, 2019 at 10:18 am
CBD isn't regulated so it's harder for the consumer to know exactly what they're buying and some veterinarians are calling for more research.
- Greater support needed to improve the treatment of knee osteoarthritison September 6, 2019 at 5:51 am
A new Curtin University-led paper has outlined that many people living with knee osteoarthritis may be needlessly suffering or receiving the wrong treatments for their symptoms, recommending a ...
- Global Osteoarthritis Drug Market Transforming Growth by top Manufacturers, Production, Market Share Value with Future Trends 2028on September 5, 2019 at 11:26 pm
Sep 06, 2019 (WiredRelease via COMTEX) -- The report attempts to offer high-quality and accurate analysis of the Global Osteoarthritis Drug Market, keeping in view market forecasts, competitive ...
- Stem cell therapy for Osteoarthritison September 4, 2019 at 1:30 pm
Innovations Medical has locations in Dallas, Frisco and Fort Worth. Call (214) 972-0353 or (817) 873-2885 for more information. You can also log onto www.innovationsmedical.com.
- Topographic modeling of early human osteoarthritis in sheepon September 4, 2019 at 11:41 am
1 Center of Experimental Orthopaedics, Saarland University, 66421 Homburg, Germany. 2 Department of Orthopaedic Surgery, Saarland University Medical Center, 66421 Homburg, Germany. Aging and injury ...
- Knee pain from osteoarthritis? New Orleans study could helpon September 3, 2019 at 8:42 pm
NEW ORLEANS — It's one of the most common ailments: Knee pain from osteoarthritis. There is no available treatment that can regrow cartilage, but now there is a new medication being tested in New ...
- Knee pain from osteoarthritis? New Orleans study may be able to helpon September 3, 2019 at 8:24 pm
It's one of the most common ailments: Knee pain from osteoarthritis. There is no available treatment that can regrow cartilage, but now there is a new medication being tested in New Orleans that hopes ...
- Osteoarthritis Therapeutics Market Report Analysis of Compound Annual Growth Rate of about 8% and Forecast Report 2023on August 29, 2019 at 10:44 pm
Aug 30, 2019 (The Expresswire) -- Global Osteoarthritis Therapeutics market report with focus on emerging technologies, regional trends, competitive landscape, regional analysis & forecast to 2023.
- Spot the Signs of Canine Osteoarthritis in Your Dogon August 28, 2019 at 8:44 am
Canine osteoarthritis (also known as arthritis, degenerative joint disease or DJD) is the most common cause of chronic pain in dogs and is estimated to affect approximately 20 percent of dogs over one ...
- New Chip Mimics Effects of Osteoarthritison August 27, 2019 at 9:55 pm
New sophisticated chip was found to mimic the effects of osteoarthritis (OA) to develop effective drugs. The chip is in the size of a coin in which cartilage can be cultivated and which can later be ...
via Bing News